Protalex, Inc. (PRTX) Reports Positive Interim Review of Phase 1b Trial of PRTX-100 in Rheumatoid Arthritis by Independent Data Safety Monitoring Committee
5/22/2013 10:06:51 AM
More...
|
Protalex, Inc. (PRTX) to Continue Phase 1b Trial of PRTX-100 in Patients With Active Rheumatoid Arthritis Following Data Safety Monitoring Committee Review
3/7/2013 10:33:09 AM
More...
|
Protalex, Inc. (PRTX) Announces Dosing of First Patient in U.S. for New Trial of PRTX-100 in Patients With Active Rheumatoid Arthritis
11/29/2012 10:01:07 AM
More...
|
Protalex, Inc. (PRTX) Announces Screening of First Patients In U.S. for New Trial of PRTX-100 in Patients With Active Rheumatoid Arthritis
11/9/2012 9:48:22 AM
More...
|
Protalex, Inc. (PRTX) to Present Phase 1b PRTX-100 Data at the 2012 American College of Rheumatology Annual Meeting
10/18/2012 10:51:04 AM
More...
|
Protalex, Inc. (PRTX) Completes Analysis of Data from Phase 1b Dose Escalation Study of PRTX-100 in Patients With Active Rheumatoid Arthritis
8/29/2012 10:06:56 AM
More...
|
Protalex, Inc. (PRTX) Findings From Phase 1b Dose Escalation Study of PRTX-100 in Patients With Active Rheumatoid Arthritis
7/26/2012 10:15:37 AM
More...
|
Protalex, Inc. (PRTX) Announces Completion of Dosing Patients in 4th Cohort of Its Phase 1b Dose Escalation Study of PRTX-100 in Patients With Active Rheumatoid Arthritis
1/17/2012 9:49:31 AM
More...
|
Protalex, Inc. (PRTX) Announces Enrollment of First Patients in 4th Cohort of Its Ongoing Phase 1b Dose Escalation Study of PRTX-100 in Patients With Active Rheumatoid Arthritis
6/27/2011 10:41:53 AM
More...
|
Protalex, Inc. (PRTX) Announces Enrollment of First Patients in 3rd Cohort of Its Ongoing Phase 1b Dose Escalation Study of PRTX-100 in Patients With Active Rheumatoid Arthritis
3/3/2011 10:20:57 AM
More...
|
|